Activated PI3K/Akt and STAT3 pathways have been suggested to contribute to neurodegenerative processes [41–43] and are targets of synthetic and natural compounds for the prevention or treatment of AD [44, 45]. The gene discussed is AKT1; the disease is Alzheimer disease.